VH GROUP+91-20-71251530 to 33response@venkys.com
VH GroupV H GROUP Explore Group

Products / Inactivated Vaccine

VH NEW BRO-MN

NEWCASTLE DISEASE & AVIAN INFECTIOUS BRONCHITIS VACCINE INACTIVATED IP

Product

NEWCASTLE DISEASE & AVIAN INFECTIOUS BRONCHITIS VACCINE INACTIVATED IP

Description

The vaccine contains Newcastle Disease Virus, LaSota strain, Avian Infectious Bronchitis Virus, Mass. M41 (GI-1 lineage), 4/91 (GI-13 lineage) and Novel Indian Nephropathogenic strains (GI-24 lineage), grown in SPF chick embryos. It is inactivated and oil-adjuvanted (VISA 15 technology) to get stable water-in-oil emulsion.

Presentation
500ml
Dosage
0.5 ml per bird

Product Information

Composition
Each dose of vaccine contains ≥ 108 EID50 of Newcastle Disease Virus, LaSota strain ≥ 106 EID50 of 3 genetic lineage of infectious Bronchitis Virus, Mass. M41 (GI-1), 4/91, (GI-13) and Novel Indian Nephro-pathogenic strains (GI-24) prior to inactivation.
Indications
Broad cross protection against the Newcastle Disease Virus genotype and Infectious Bronchitis Virus genotypes prevalent.
Route of administration
Subcutaneous or Intramuscular.
Shelf Life
24 months from date of manufacture.
Storage
Between 2 to 8°C. Do not freeze.

Instructions

Take out vaccine bottle from refrigerator. Bring it to room temperature for vaccination.

  1. Use only by S/C or I/M route by using 20/21G ½ inch needle.
  2. Shake bottle before use and frequently during vaccination.
Side Effects

Not observed.

Withdrawal

Not required.

Transport

On ice in thermos flask / thermocol box.